Trial site
Gyeongsang National University Hospital
- 31running trials
- 9closed trials
The trials here
What the 40 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease13 trials
- Lung cancer11 trials
- Gastric and oesophageal cancer4 trials
- Liver and biliary tract cancer4 trials
- Myeloproliferative neoplasms2 trials
- Atrial fibrillation1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Follicular lymphoma1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- and 3 more
- Phase
- Phase 316 trials
- Phase 25 trials
- Phase 43 trials
- Phase 1/21 trial
- Status
- Recruiting17 trials
- Active, not recruiting12 trials
- Completed6 trials
- Not yet recruiting2 trials
- Terminated2 trials
- Withdrawn1 trial
- Lead sponsor
- Samsung Medical Center6 trials
- Chonnam National University Hospital4 trials
- Taiho Oncology, Inc.4 trials
- Daiichi Sankyo3 trials
- Eli Lilly and Company3 trials
- and 17 more
Running trials
Recruiting
Recruiting
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
Recruiting
Recruiting
Recruiting
OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
Recruiting
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Active, not recruiting
Active, not recruiting
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Recruiting
Recruiting
Active, not recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Recruiting
Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions
Recruiting
Recruiting
Recruiting
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Active, not recruiting
Active, not recruiting
Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease10 recruiting
- Lung cancer4 recruiting
- Gastric and oesophageal cancer2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Heart failure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Rheumatoid arthritis1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Terminated
Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Completed
Terminated
Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis
Completed
Completed
Completed
Completed
Completed
Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection
Site data: ClinicalTrials.govUpdated 18 Nov 2026